Medroxyprogesterone
Acetate (WHO Pre-Qualified)
CAS number: 71-58-9
General information about the Medroxyprogesterone acetate sterile active pharmaceutical ingredient
Medroxyprogesterone acetate sterile as active pharmaceutical ingredient (API) is a steroidal progestin, a synthetic variant of the human hormone progesterone, commonly abbreviated as MPA. Medroxyprogesterone acetate sterile is used for contraception, menopausal hormone therapy, abnormal bleeding and endometriosis. Medroxyprogesterone acetate sterile API works in the same way as natural progesterone,changing the proliferative phase to the secretory phase of the endometrium. Medroxyprogesterone acetate sterile comes in injectable suspension forms.
Axplora manufactures Medroxyprogesterone acetate sterile API
Medroxyprogesterone acetate sterile API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Medroxyprogesterone acetate sterile API is produced by Farmabios, our WHO, EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Medroxyprogesterone acetate sterile API is sterilized by gamma irradiation. Medroxyprogesterone acetate sterile API is commercially available as micronized grade specifically designed around various formulation requirements. Feel free to contact us if you need any additional information about Medroxyprogesterone acetate sterile API.
- Therapeutic area Contraceptive
-
Monograph
PH.EUR.
USP - Available grade Micronized
-
Regulatory documentation
US DMF#
WHO DMF - Produced in GRO